QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fourth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Page |
||||||
Item 1. |
1 | |||||
1 | ||||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
Item 2. |
18 | |||||
Item 3. |
22 | |||||
Item 4. |
23 | |||||
Item 2. |
23 | |||||
Item 6. |
23 |
Assets: |
||||
Current assets: |
||||
Cash |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total current assets |
||||
Investments held in Trust Account |
||||
|
|
|||
Total Assets |
$ |
|||
|
|
|||
Liabilities and Stockholders’ Equity: |
||||
Current liabilities: |
||||
Accounts payable |
$ | |||
Accrued expenses |
||||
Franchise tax payable |
||||
Working capital loan - related party |
||||
|
|
|||
Total current liabilities |
||||
Deferred underwriting commissions |
||||
Derivative warrant liabilities |
||||
|
|
|||
Total liabilities |
||||
Commitments and Contingencies |
||||
Class A common stock, $ |
||||
Stockholders’ Equity: |
||||
Preferred stock, $ |
||||
Class A common stock, $ |
||||
Class B common stock, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total stockholders’ equity |
||||
|
|
|||
Total Liabilities and Stockholders’ Equity |
$ |
|||
|
|
For The Three Months Ended June 30, 2021 |
For The Period From January 4, 2021 (inception) through June 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Administrative expenses - related party |
||||||||
Franchise tax expenses |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expenses) |
||||||||
Change in fair value of derivative warrant liabilities |
( |
) | ( |
) | ||||
Change in fair value of working capital loan - related party |
( |
) | ( |
) | ||||
Financing costs - derivative warrant liabilities |
— | ( |
) | |||||
Net gain from investments held in Trust Account |
||||||||
|
|
|
|
|||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding of Class A common stock subject to possible redemption |
||||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ | $ | ||||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding of non-redeemable common stock |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share, non-redeemable common stock |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
Common Stock |
Total |
|||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-In |
Accumulated |
Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||||||||||||||
Balance - January 4, 2021 (inception) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
Issuance of Class B common stock to Sponsor |
— |
— |
— |
|||||||||||||||||||||||||
Sale of units in initial public offering, less fair value of public warrants |
— |
— |
— |
|||||||||||||||||||||||||
Offering costs |
— |
— |
— |
— |
( |
) | — |
( |
) | |||||||||||||||||||
Excess of cash received over fair value of private placement warrants |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Common stock subject to possible redemption |
( |
) | ( |
) | — |
— |
( |
) | — |
( |
) | |||||||||||||||||
Net loss |
— |
— |
— |
— |
— | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (unaudited) |
( |
) | ||||||||||||||||||||||||||
Offering costs - rever s al of over-accruals |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Common stock subject to possible redemption |
— |
— |
— |
|||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
General and administrative expenses paid by Sponsor in exchange for issuance of Class B common stock |
||||
Change in fair value of derivative warrant liabilities |
||||
Change in fair value of working capital loan - related party |
||||
Financing costs - derivative warrant liabilities |
||||
Net gain from investments held in Trust Account |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Franchise tax payable |
||||
Accounts payable |
||||
Accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities |
||||
Cash deposited in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from note payable to related party |
||||
Proceeds received from initial public offering, gross |
||||
Proceeds received from private placement |
||||
Offering costs paid |
( |
) | ||
Net cash provided by financing activities |
||||
Net change in cash |
||||
Cash - beginning of the period |
||||
Cash - end of the period |
$ |
|||
Supplemental disclosure of noncash activities: |
||||
Offering costs paid by Sponsor in exchange for issuance of Class B common stock |
$ | |||
Offering costs included in accrued expenses |
$ | |||
Deferred underwriting commissions in connection with the initial public offering |
$ | |||
Initial value of Class A common stock subject to possible redemption |
$ | |||
Change in initial value of Class A common stock subject to possible redemption |
$ | ( |
) | |
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For The Three Months Ended June 30, 2021 |
For The Period From January 4, 2021 (inception) through June 30, 2021 |
|||||||
Class A common stock subject to possible redemption |
||||||||
Numerator: Earnings allocable to common stock subject to possible redemption |
||||||||
Income from investments held in Trust Account |
$ | $ | ||||||
Less: Company’s portion available to be withdrawn to pay taxes |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net income attributable to Class A common stock subject to possible redemption |
$ | $ | ||||||
|
|
|
|
|||||
Denominator: Weighted average Class A common stock subject to possible redemption |
||||||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption |
||||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A common stock subject to possible redemption |
$ |
$ |
||||||
|
|
|
|
|||||
Non-redeemable common stock |
||||||||
Numerator: Net Loss minus Net Earnings |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Net income allocable to Class A common stock subject to possible redemption |
||||||||
|
|
|
|
|||||
Non-redeemable net loss |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
|||||
Denominator: Weighted average non-redeemable common stock |
||||||||
Basic and diluted weighted average shares outstanding, non-redeemable common stock |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share, non-redeemable common stock |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
• |
in whole and not in part; |
• |
at a price of $ |
• |
upon a minimum of 30 days |
• |
if, and only if, the last reported sale price of the Class A common stock equals or exceeds $ day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• |
in whole and not in part; |
• |
at $ |
• |
if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $ |
• |
if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and |
• |
if, and only if, there is an effective registration statement covering the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in the initial Business Combination) issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | $ | $ | |||||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities - Public |
$ | $ | $ | |||||||||
Derivative warrant liabilities - Private |
$ | $ | $ | |||||||||
Working capital loan - related party |
$ | $ | $ |
As of March 2, 2021 |
As of March 31, 2021 |
As of June 30, 2021 |
||||||||||
Volatility |
% | % | % | |||||||||
Stock price |
$ | $ | $ | |||||||||
Expected life of the options to convert |
||||||||||||
Risk-free rate |
% | % | % | |||||||||
Dividend yield |
% | % | % |
Liabilities at January 4, 2021 (inception) |
$ | |||
Issuance of Public and Private Warrants |
||||
Change in fair value of derivative warrant liabilities |
||||
Liabilities at March 31, 2021 |
||||
Fair value of working capital loan |
||||
Change in fair value of derivative warrant liabilities |
||||
Change in fair value of working capital loan |
||||
Transfer of Public Warrants to level 1 |
( |
) | ||
Liabilities at June 30, 2021 |
$ | |||
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds. |
Item 6. |
Exhibits. |
* |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
Dated: August 16, 2021 | KENSINGTON CAPITAL ACQUISITION CORP. II | |||||
By: | /s/ Justin Mirro | |||||
Name: Justin Mirro | ||||||
Title: Chief Executive Officer |